Latest Financial Health News

CTI Logistics Limited anticipates a significant 55% increase in profit before tax for the half year ending December 2025, driven by robust revenue growth and operational improvements in Western Australia.

Orthocell has lodged a regulatory application to distribute its nerve repair product Remplir™ across the EU and UK, aiming to tap into a $750 million market with approval expected by Q3 2026.

Korab Resources Limited reported a positive cash flow for the December 2024 quarter, maintaining a strong liquidity position with funding to support its exploration activities for over 17 quarters.

Assetora Limited has resolved a recent receivership by fully settling its outstanding debt, bringing external administration to a close within a day.

Macquarie Group Limited has announced an ordinary dividend of AUD 1.6883 per security for its perpetual capital notes, payable in March 2026. The distribution features a partially franked yield reflecting current market interest rates.

APA Group has announced a modest 1.9% increase in its interim distribution to 27.5 cents per security for the half year ending December 2025, maintaining steady income growth for investors.

Matrix Composites & Engineering has fully redeemed its $7.5 million convertible note, replacing it with a new term loan facility from NAB that offers improved terms and a streamlined debt structure.

Nuix Limited has announced its acquisition of Paris-based graph intelligence firm Linkurious for up to €20 million, aiming to enhance its AI-driven data analytics capabilities and expand its global footprint.

Queste Communications reported a slight net cash outflow from operations in November 2025 but maintains robust liquidity supported by a substantial loan facility and liquid ASX-listed investments.

QPM Energy Limited has had its trading suspension lifted following the announcement of a strategic investment term sheet and a capital raising, signaling renewed momentum for the energy company.

Microequities Asset Management Group delivered a robust November trading update, driven by strong returns in its Pure Microcap Value Fund and a final performance payment from a special purpose vehicle, pushing half-year profits above last year’s level.

Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.